Back
Carisma Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
CARM
Carisma Therapeutics, Inc.
Last Price:
$0.04
Seasonality Move:
-21.27%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARM is experiencing selling pressure, which indicates risk of future bearish movement.
Carisma Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.05 | Sell |
| 20-day SMA: | 0.05 | Sell |
| 50-day SMA: | 0.05 | Sell |
| 200-day SMA: | 0.24 | Sell |
| 8-day EMA: | 0.05 | Sell |
| 20-day EMA: | 0.05 | Sell |
| 50-day EMA: | 0.08 | Sell |
| 200-day EMA: | 0.31 | Sell |
Carisma Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 41.47 | Sell |
| Chaikin Money Flow: | -201420 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.04 - 0.06) | Sell |
| Bollinger Bands (100): | (0.04 - 0.3) | Sell |
Carisma Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Carisma Therapeutics, Inc. Stock
Is Carisma Therapeutics, Inc. Stock a Buy?
-
Carisma Therapeutics, Inc. share price is 0.04 while CARM 8-day simple moving average is 0.05, which is a Sell signal.
-
The stock price of CARM is 0.04 while Carisma Therapeutics, Inc. 20-day SMA is 0.05, which makes it a Sell.
-
Carisma Therapeutics, Inc. 50-day simple moving average is 0.05 while CARM share price is 0.04, making it a Sell technically.
-
CARM stock price is 0.04 and Carisma Therapeutics, Inc. 200-day simple moving average is 0.24, creating a Sell signal.
CARM Technical Analysis vs Fundamental Analysis
Sell
20
Carisma Therapeutics, Inc. (CARM)
is a Sell
Is Carisma Therapeutics, Inc. a Buy or a Sell?
-
Carisma Therapeutics, Inc. stock is rated a SellThe current Carisma Therapeutics, Inc. [CARM] share price is $0.04. The Score for CARM is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Carisma Therapeutics, Inc. Stock Info
Market Cap:
1.8M
Price in USD:
0.04
Share Volume:
402.8K
Carisma Therapeutics, Inc. 52-Week Range
52-Week High:
1.27
52-Week Low:
0.03
Sell
20
Carisma Therapeutics, Inc. (CARM)
is a Sell
Carisma Therapeutics, Inc. Share Price Forecast
-
What is the Carisma Therapeutics, Inc. stock price today?The Carisma Therapeutics, Inc. stock price is 0.04 USD today.
-
Will CARM stock go up or go down?Carisma Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Carisma Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Carisma Therapeutics, Inc. is overvalued.
Is Carisma Therapeutics, Inc. Stock a Buy?
-
Carisma Therapeutics, Inc. share price is 0.04 while CARM 8-day exponential moving average is 0.05, which is a Sell signal.
-
The stock price of CARM is 0.04 while Carisma Therapeutics, Inc. 20-day EMA is 0.05, which makes it a Sell.
-
Carisma Therapeutics, Inc. 50-day exponential moving average is 0.08 while CARM share price is 0.04, making it a Sell technically.
-
CARM stock price is 0.04 and Carisma Therapeutics, Inc. 200-day simple moving average is 0.31, creating a Sell signal.
Fundamental Analysis of Carisma Therapeutics, Inc.
Is Carisma Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.17 per share.
Technical Analysis of Carisma Therapeutics, Inc.
Should I short Carisma Therapeutics, Inc. stock?
-
CARM Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Carisma Therapeutics, Inc. is a Sell
-
Carisma Therapeutics, Inc. Relative Strength Index (RSI) is 41.47, which suggest Carisma Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Carisma Therapeutics, Inc. is (0.04 - 0.06), which suggest Carisma Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Carisma Therapeutics, Inc. is (0.04 - 0.3), which suggest Carisma Therapeutics, Inc. is a Sell
* Carisma Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.